NCT06859112Befejeződött
The Effect Of Logotherapy-Based Psychoeducatıon Applıed To Famıly Members Of Indıvıduals Dıagnosıs Of Schızophrenıa
The Effect Of Logotherapy-Based Psychoeducatıon Applıed To Famıly Members Of Indıvıduals Dıagnosıs Of Schızophrenıa On Meanıng In Lıfe, Hope And Depressıon And Theır Psychoeducatıon Experıences
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. jún. 22.
Rövid összefoglaló (regiszter, angolul)
Objective: This study aimed to determine the effects of logotherapy-based psychoeducation applied to family members of individuals diagnosed with schizophrenia on meaning in life, hope, and depression, and to examine experiences related to the psychoeducation process. Materials and Methods: Using a parallel convergent mixed methods design, the quantitative dimension of the study was designed as a randomized controlled trial, and the qualitative dimension was designed using a phenomenological method. The research was conducted between November 2023 and August 2025 with family members of individuals diagnosed with schizophrenia who were being followed up in the mental health and diseases outpatient clinics of a city hospital in Istanbul. A total of 40 family members were included in the study, 19 in the experimental group and 21 in the control group. Quantitative data were collected using the Demographic Information Form, Meaning in Life Scale, Herth Hope Scale, and Beck Depression Inventory, while qualitative data were collected using a Semi-Structured Interview Form. Pre-test measurements were performed on family members in both the experimental and control groups after randomization. Subsequently, individuals in the experimental group received an eight-session Logotherapy-Based Psychoeducation program individually online. Family members who completed the psychoeducation program underwent post-test measurements the following day, and qualitative data were collected through individual in-depth interviews. Family members in the control group received no intervention for eight weeks, after which post-test measurements were taken. Quantitative data were analyzed using the Wilcoxon signed-rank test, Mann Whitney U test, and t-test; qualitative data were analyzed using Colaizzi's phenomenological data analysis method.
- Állapot (regiszter)
- Befejeződött
- Vizsgálattípus
- Beavatkozással járó
- Résztvevők száma
- 42 (tényleges)
- Első benyújtás
- 2024. dec. 30.
- Kezdés
- 2023. dec. 22.
- Elsődleges befejezés
- 2025. jún. 15.
- Fő szponzor
- aslı zeynep sipahi
- Betegségek
- Skizofrénia
- NCT-szám
- NCT06859112
Mit vállalsz
- Vizsgálat típusa: Beavatkozással járó
- Bevont résztvevők: 42
- 2023. dec. 22. és az elsődleges befejezés (2025. jún. 15.) között
- 1 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Más betegség
- Failure to attend at least two psychoeducation sessions in total
- Failure to complete or incomplete completion of data collection forms
A regiszterben nem jelölt feltételek
- Participation Criteria
- Voluntary participation in the study
- Being between 18 and 65 years of age
- Having a family member diagnosed with schizophrenia according to DSM-5 diagnostic criteria and receiving outpatient treatment
- The individual diagnosed with schizophrenia must have been under follow-up for at least one year Exclusion Criteria
- Receiving treatment for a mental disorder
- Receiving psychotherapy
Életkor a regiszterben: 18 év – 65 év · Nem: nők és férfiak · Egészséges önkénteseket is fogad
Helyszínek (1)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| Uskudar University | Ümraniye | Törökország | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.